Ann: GENERAL: AFT: Maxigesic IV IND Approved by FDA

• Release Date: 24/03/16 09:12
• Summary: GENERAL: AFT: Maxigesic IV IND Approved by FDA
• Price Sensitive: No
• Download Document  686B

					AFT
24/03/2016 09:12
GENERAL
PRICE SENSITIVE
REL: 0912 HRS AFT Pharmaceuticals Limited

GENERAL: AFT: Maxigesic IV IND Approved by FDA

Australia and New Zealand pharmaceutical company, AFT Pharmaceuticals, has
today announced that the IND [Investigational New Drug Application] for
Maxigesic IV has now been approved by the US FDA on 21st March 2016.

This is the first key step in the regulatory process to seek approval for
Maxigesic IV in the USA. The first clinical pharmacokinetic study conducted
under the IND in CCST, Christchurch, New Zealand has now been opened and
patient enrolment will commence in April.
End CA:00279815 For:AFT    Type:GENERAL    Time:2016-03-24 09:12:18